Clinical Study

Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study

Figure 1

Classification of CD155 expression on BC tissues. (a) Overexpression of CD155. (b) Low expression of CD155.
(a)
(b)